1. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989; 107:453–64.
Article
2. Kerrigan-Baumrind LA, Quigley HA, Pease ME, et al. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000; 41:741–8.
3. Johnson CA, Adams AJ, Casson EJ, et al. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch Ophthalmol. 1993; 111:645–50.
Article
4. Johnson ca, Adams AJ, Casson EJ, Brandt JD. Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry. Arch Ophthalmol. 1993; 111:651–6.
Article
5. Wall M, Ketoff KM. Random dot motion perimetry in patients with glaucoma and in normal subjects. Am J Ophthalmol. 1995; 120:587–96.
Article
6. Bosworth CF, Sample SA, Gupta N, et al. Motion automated perimetry identifies early glaucomatous field defects. Arch Ophthalmol. 1998; 116:1153–8.
Article
7. Glovinsky Y, Quigley HA, Pease ME. Foveal ganglion cell loss in size dependent on experimental glaucoma. Invest Ophthalmol Vis Sci. 1991; 32:484–91.
8. Quigley HA, Dunkelberger GR, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology. 1988; 95:357–63.
Article
9. Kelly DH. Frequency doubling in visual responses. J Opt Soc Am. 1966; 56:1628–33.
Article
10. Johnson CA, Samuels SJ. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci. 1997; 38:413–25.
11. Quigley HA. Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology. Am J Ophthalmol. 1998; 125:819–29.
12. Brusini P, Salvetat ML, Zeppieri M, Parisi L. Frequency doubling technology perimetry with the Humphrey Matrix 30-2 test. J Glaucoma. 2006; 15:77–83.
Article
13. Ko BS, Kim CY, Hong YJ. Correlation between optic disc tomography and frequency doubling technology in glaucoma suspect. J Korean Ophthalmol Soc. 2003; 44:2040–6.
14. Anderson AJ, Johnson CA. Frequency-doubling technology perimetry and optical defocus. Invest Ophthalmol Vis Sci. 2003; 44:4147–52.
Article
15. Artes PH, Nicolela MT, McCormick TA, et al. Effects of blur and repeated testing on sensitivity estimates with frequency doubling perimetry. Invest Ophthalmol Vis Sci. 2003; 44:646–52.
Article
16. Ito A, Kawabata H, Fujimoto N, Adachi-Usami E. Effect of myopia on frequency-doubling perimetry. Invest Ophthalmol Vis Sci. 2001; 42:1107–10.
17. Heeg GP, Stoutenbeek R, Jansonius NM. Strategies for improving the diagnostic specificity of the frequency doubling perimeter. Acta Ophthalmol Scand. 2005; 83:53–6.
Article
18. Heeg GP, Ponsioen TL, Jansonius NM. Learning effect, normal range, and test-retest variability of Frequency Doubling Perimetry as a function of age, perimetric experience, and the presence or absence of glaucoma. Ophthalmic Physiol Opt. 2003; 23:535–40.
Article
19. Joson PJ, Kamantigue ME, Chen PP. Learning effects among perimetric novices in frequency doubling technology perimetry. Ophthalmology. 2002; 109:757–60.
Article
20. Iester M, Capris P, Pandolfo A, et al. Learning effect, short-term fluctuation, and long-term fluctuation in frequency doubling technique. Am J Ophthalmol. 2000; 130:160–4.
Article
21. Brush MB, Chen PP. Test-retest variability in glaucoma patients tested with C-20-1 screening-mode frequency doubling technology perimetry. J Glaucoma. 2004; 13:273–7.
Article
22. Adams CW, Bullimore MA, Wall M, et al. Normal aging effects for frequency doubling technology perimetry. Optom Vis Sci. 1999; 76:582–7.
Article
23. Legge GE, Mullen KT, Woo GC, Campbell FW. Tolerance to visual defocus. J Opt Soc Am A. 1987; 4:851–63.
Article
24. Brusini P, Salvetat ML, Zeppieri M, Parisi L. Frequency doubling technology perimetry with the Humphrey Matrix 30-2 test. J Glaucoma. 2006; 15:77–83.
Article
25. Kogure S, Toda Y, Crabb D, et al. Agreement between frequency doubling perimetry and static perimetry in eyes with high tension glaucoma and normal tension glaucoma. Br J Ophthalmol. 2003; 87:604–8.
Article
26. Anderson AJ, Johnson CA, Fingeret M, et al. Characteristics of the normative database for the Humphrey matrix perimeter. Invest Ophthalmol Vis Sci. 2005; 46:1540–8.
Article
27. Haymes SA, Hutchison DM, McCormick TA, et al. Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study. Invest Ophthalmol Vis Sci. 2005; 46:547–54.
Article